/ CompletedNot Applicable Evaluate the Safety and Efficacy of a Steerable Catheter in the Treatment of Vascular Interventional Access : a Prospective, Muti-center, Single-arm Study
This is a prospective, multicenter, single-arm clinical trial to evaluate safety and efficacy of a steerable catheter in the establishment of vascular intervention access. five centers participate in this study. The total enrollment number is 68. In the procedure of vascular interventional surgery or angiography diagnosis, the steerable catheter are used to building vascular interventional access. Evaluate the safety and efficacy of the product, by the observation and record the relative index of subjects intraoperative and postoperative (discharge) before and after 30 days .
100 Clinical Results associated with Hangzhou Weiqiang Medical Technology Co., Ltd.
0 Patents (Medical) associated with Hangzhou Weiqiang Medical Technology Co., Ltd.
01 Nov 2021·Annals of vascular surgery
Endovascular Repair of Aortic Arch Aneurysm with a New Modular Double Inner Branch Stent Graft
Author: Liu, Xiaoping ; Guo, Wei ; Wang, Yongsheng ; Zhang, Hongpeng ; Ren, Wei
Endovascular repair of an aortic arch aneurysm has made great progress in the last 10 years. Custom-made branched stent grafts have been used, and preliminary results have been promising. To reduce the effect of aortic arch anatomical variations on indications, we designed a new off-the-shelf modular double inner branch stent-graft system. This case is the "First-in-Man" study for the device. A 74-year-old man presented with an asymptomatic saccular aneurysm and an ulcer lesion of the aortic arch. Left common carotid artery (LCCA) and left subclavian artery bypass was performed before endovascular repair. The modular stents reconstructed the innominate artery and LCCA. A follow-up on the computed tomography angiography 6-month results showed that the new device is safe and feasible for patients who are unfit for conventional surgery.
100 Deals associated with Hangzhou Weiqiang Medical Technology Co., Ltd.
100 Translational Medicine associated with Hangzhou Weiqiang Medical Technology Co., Ltd.